{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:44Z","timestamp":1791928964506,"version":"4.3.4"},"reference-count":37,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.1167\/iovs.67.5.57","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:30:51Z","timestamp":1779283851000},"page":"57","source":"Crossref","is-referenced-by-count":0,"title":["GSH-Responsive PBAE Polymers for IL-12 mRNA Delivery in Melanoma Immunotherapy"],"prefix":"10.1167","volume":"67","author":[{"given":"Xiaoli","family":"Bao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijing","family":"Ye","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huasheng","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"11","key":"bib1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.tcb.2025.01.009","article-title":"Decoding melanoma's cellular mosaic to unlock immunotherapy potential","volume":"35","author":"Pozniak","year":"2025","journal-title":"Trends Cell Biol"},{"issue":"15","key":"bib2","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: from diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"issue":"5","key":"bib3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41590-022-01141-1","article-title":"A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance","volume":"23","author":"Huang","year":"2022","journal-title":"Nat Immunol"},{"issue":"1","key":"bib4","doi-asserted-by":"publisher","first-page":"2394252","DOI":"10.1080\/21645515.2024.2394252","article-title":"Immunotherapy and delivery systems for melanoma","volume":"20","author":"Liu","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"bib5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11864-019-0607-8","article-title":"Targeted therapy and immunotherapy for melanoma in Japan","volume":"20","author":"Namikawa","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"bib6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/cancers11060834","article-title":"Uveal melanoma, angiogenesis and immunotherapy, is there any hope?","volume":"11","author":"Castet","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/13543784.2021.1898587","article-title":"Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment","volume":"30","author":"Masaoutis","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"issue":"24","key":"bib8","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.1021\/acsnano.4c00063","article-title":"Delivery of mRNA encoding interleukin-12 and a stimulator of interferon genes agonist potentiates antitumor efficacy through reversing T cell exhaustion","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2022.03.021","article-title":"Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy","volume":"345","author":"Liu","year":"2022","journal-title":"J Control Release"},{"issue":"108","key":"bib10","doi-asserted-by":"publisher","first-page":"eads1328","DOI":"10.1126\/sciimmunol.ads1328","article-title":"An Il12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses","volume":"10","author":"Aunins","year":"2025","journal-title":"Sci Immunol"},{"issue":"3","key":"bib11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.ymthe.2025.01.037","article-title":"PBAE-PEG-based lipid nanoparticles for lung cell-specific gene delivery","volume":"33","author":"Liu","year":"2025","journal-title":"Mol Ther"},{"issue":"51","key":"bib12","doi-asserted-by":"publisher","first-page":"17578","DOI":"10.1021\/acs.nanolett.5c04269","article-title":"PBAE-PEG\/lipid nanoparticle delivery of RNA for the creation of genetically engineered lung cancer mouse models","volume":"25","author":"Liu","year":"2025","journal-title":"Nano Lett"},{"issue":"10","key":"bib13","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acsbiomaterials.4c00897","article-title":"Nanomedicines with versatile GSH-responsive linkers for cancer theranostics","volume":"10","author":"Ding","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"issue":"3","key":"bib14","first-page":"300","article-title":"Histopathologic classification and prognostic factors of melanoma: a 2021 update","volume":"156","author":"Bobos","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"issue":"2","key":"bib15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"15","key":"bib16","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/ijms21155314","article-title":"Targeting epigenetic modifications in uveal melanoma","volume":"21","author":"Chokhachi Baradaran","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"bib17","doi-asserted-by":"publisher","first-page":"znaf130","DOI":"10.1093\/bjs\/znaf130","article-title":"Management of liver metastases from uveal melanoma","volume":"112","author":"Huibers","year":"2025","journal-title":"Br J Surg"},{"issue":"13","key":"bib18","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.3390\/cancers14133094","article-title":"Recent advances and challenges in uveal melanoma immunotherapy","volume":"14","author":"Fu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1619150","DOI":"10.3389\/fcell.2025.1619150","article-title":"Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistance","volume":"13","author":"Song","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"125843","DOI":"10.1016\/j.ijpharm.2025.125843","article-title":"Co-delivery of IL-12 mRNA and small-molecule prodrug with lung-tropic lipid nanoparticles for synergistic cancer therapy","volume":"681","author":"Jin","year":"2025","journal-title":"Int J Pharm"},{"issue":"1","key":"bib21","doi-asserted-by":"publisher","first-page":"29649","DOI":"10.1038\/s41598-025-14750-1","article-title":"CARG-2020 targets IL-12, IL-17, and PD-L1 pathways to effectively treat melanoma and breast cancer","volume":"15","author":"Ahmadi","year":"2025","journal-title":"Sci Rep"},{"issue":"16","key":"bib22","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"Del Vecchio","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"5","key":"bib23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","article-title":"Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours","volume":"4","author":"Mansurov","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"bib24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s43018-020-0095-6","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat Cancer"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"575597","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized interleukin-12 for cancer immunotherapy","volume":"11","author":"Nguyen","year":"2020","journal-title":"Front Immunol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"122185","DOI":"10.1016\/j.biomaterials.2023.122185","article-title":"Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors","volume":"300","author":"Neshat","year":"2023","journal-title":"Biomaterials"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"385135","DOI":"10.1155\/2014\/385135","article-title":"Preparation and characterization of novel PBAE\/PLGA polymer blend microparticles for DNA vaccine delivery","volume":"2014","author":"Balashanmugam","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"35","key":"bib28","doi-asserted-by":"publisher","first-page":"e2400194121","DOI":"10.1073\/pnas.2400194121","article-title":"Supramolecular assembly of polycation\/mRNA nanoparticles and in vivo monocyte programming","volume":"121","author":"Hu","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jare.2024.07.038","article-title":"Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety","volume":"73","author":"Tan","year":"2025","journal-title":"J Adv Res"},{"issue":"15","key":"bib30","doi-asserted-by":"publisher","first-page":"e2405056","DOI":"10.1002\/adhm.202405056","article-title":"HGF\/c-Met axis-targeted nanotherapy via GSH-responsive polymer platforms suppresses uveal melanoma metastasis","volume":"14","author":"Tao","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"103965","DOI":"10.1016\/j.redox.2025.103965","article-title":"Combination of YAP inhibition and photodynamic therapy induces dual DNA damage and activates STING pathway to enhance immunotherapy in uveal melanoma","volume":"89","author":"Zhang","year":"2026","journal-title":"Redox Biol"},{"issue":"44","key":"bib32","doi-asserted-by":"publisher","first-page":"eadh1582","DOI":"10.1126\/sciadv.adh1582","article-title":"An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy","volume":"9","author":"Chen","year":"2023","journal-title":"Sci Adv"},{"issue":"4","key":"bib33","doi-asserted-by":"publisher","first-page":"eabq3104","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci Adv"},{"issue":"9","key":"bib34","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/onc.2011.309","article-title":"Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma","volume":"31","author":"de Lange","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"bib35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/cbt.11.2.13842","article-title":"Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2\/PI3K\/MMP pathway in a murine choroidal melanoma model","volume":"11","author":"Chen","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"e001481","DOI":"10.1136\/jitc-2020-001481","article-title":"In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis","volume":"9","author":"Kim","year":"2021","journal-title":"J Immunother Cancer"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"4521807","DOI":"10.1155\/2016\/4521807","article-title":"Animal models of uveal melanoma: methods, applicability, and limitations","volume":"2016","author":"Stei","year":"2016","journal-title":"Biomed Res Int"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:22Z","timestamp":1791927142000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.5.57","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}